ArticleTranslational cancer research2026
A real-world feasibility and safety study of anlotinib monotherapy in heavily pretreated or temozolomide-ineligible recurrent malignant glioma.
Xudong Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.